Oncolytics Biotech ( ($ONCY) ) has shared an update. On October 10, 2025, Oncolytics Biotech Inc. submitted a corporate presentation to the ...

Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...

Moat Index gains in September, thanks to tech names offsetting weakness in defensive sectors like consumer staples. Read more ...

Trace amounts of double-stranded RNA (dsRNA) byproduct produced during in vitro transcription can interfere with downstream in vivo administration by triggering unwanted immune responses. PrimeCap™ T7 ...

Members of Congress are increasingly leveraging their inside knowledge of forthcoming policy changes and economic ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has provided an announcement. CSPC Pharmaceutical Group Limited has received approval from the U.S. FDA ...

If you had invested $10,200 on the day Google first traded publicly and never sold a share, your investment would have grown to roughly $1 million today. But is Google parent Alphabet still a ...

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR) ...

NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today ...

These pressures demand more resilient, forward-looking sourcing strategies. This article explores practical approaches to safeguarding API quality and availability. Key considerations include rigorous ...

Starpharma has struck a headline $855m deal with Big Pharma Genentech to develop drugs that include the company's dendremer based candidates.